2seventy bio Alternatives & Competitors
12 companies similar to 2seventy bio — It’s about time we think smarter and faster than cancer.
Companies similar to 2seventy bio
MetiMedi Co., Ltd.
MetiMedi is developing a first-in-class oral immunotherapeutic small molecule in Phase 2 f...
Korea South
Kite Pharma
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
Santa Monica, United Stat...
Faeth Therapeutics
Unlocking the power of metabolism to treat cancer.
United States
Tango Therapeutics
Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of preci...
Boston, United States
Track all 2seventy bio competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
Nkarta, Inc.
A New Way Forward for Autoimmune Disease
South San Francisco, Unit...
Xilio Therapeutics, Inc.
Focused on harnessing the immune system to achieve deep and durable clinical responses to...
Waltham, United States
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
London, United Kingdom
Pyxis Oncology
Charting a course to therapeutics for difficult-to-treat cancer.
Boston, United States
Apollomics
We are a biopharmaceutical company committed to the discovery and development of mono- and...
Foster City, United State...
Bicara Therapeutics
Pioneering bifunctional antibodies for targeted tumor modulation
Boston, United States
About 2seventy bio
2seventy bio is a progressive player in the field of immuno-oncology cell therapy, founded in 2021. With its headquarters in the United States, the company is dedicated to altering the future of cancer treatment. Their innovative approach is encapsulated in the slogan, "It’s about time we think smarter and faster than...
Research & Development, Clinical Trials, Product Development, Scientific Resources Provision, Medicines Access and Support
Patients with Cancer, Patients with Hematological Diseases, Neurological and Psychiatric Patients, Healthcare Providers, Patient Advocacy Groups, Medical Researchers
Immuno-oncology, Cell Therapy, Cancer Treatment, Cancer Cell Metabolism, Genomics, Immune Response, Tumor Cell Targeting, Cellular Therapies, Cancer Cell Biology, Genetics, Therapeutic Pipeline, Disruptive Therapies, Oncology Research, Innovative Cancer Therapies
B2B2C, B2B
Product Sales, Licensing, Value Based Pricing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches 2seventy bio and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at 2seventy bio on 3 Jul 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
